Clin Infect Dis by Tohme, Rania A. & Holmberg, Scott D.
Transmission of Hepatitis C Virus Infection Through Tattooing 
and Piercing: A Critical Review
Rania A. Tohme and Scott D. Holmberg
Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
(NCHHSTP), Centers for Disease Control and Prevention, Atlanta, Georgia
Abstract
Tattoos and piercings are increasing, especially among youths, but the risk of hepatitis C virus 
(HCV) infection from these practices has not been adequately assessed and there are conflicting 
findings in the literature. We evaluated the risk of HCV infection from tattooing and piercing 
using the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Studies 
that specified the venue of tattooing and/or piercing showed no definitive evidence for an 
increased risk of HCV infection when tattoos and piercings were received in professional parlors. 
However, the risk of HCV infection is significant, especially among high-risk groups (adjusted 
odds ratio, 2.0–3.6), when tattoos are applied in prison settings or by friends. Prevention 
interventions are needed to avoid the transmission of hepatitis C from tattooing and piercing in 
prisons, homes, and other potentially nonsterile settings. Youths also should be educated on the 
need to have tattoos and piercings performed under sterile conditions to avoid HCV infection.
Hepatitis C Virus (HCV) infection, which is primarily transmitted through percutaneous 
exposure to contaminated blood, affects approximately 3 million Americans and is the 
leading cause of liver cancer in the United States [1]. In 2009, an estimated 16 000 new 
HCV infections occurred in the United States [2]. Although injection drug use (IDU) was 
the main mode of transmission among patients with available risk factor information, 
approximately 20% of patients denied exposure to traditional risk factors, such as IDU or 
other parenteral exposure [2]. From 1994 through 2006, recent tattooing and piercing were 
reported by 6% and 5% of respondents, respectively, with acute HCV infection in the 
Sentinel County Surveillance System [3]. However, more than two-thirds of these patients 
also reported exposure to other risk factors, including IDU, which prevented drawing sound 
conclusions about the actual mode of transmission in those cases [3].
Although the practice of tattooing and piercing has been present for thousands of years, the 
numbers of tattoos and piercings have been increasing during the past decade, particularly 
among youths [4–7]. A 2004 survey among persons aged 18–50 years in the United States 
found that 24% of respondents had at least 1 tattoo and 14% had ever had body piercings 
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[4]. Because of conflicting findings reported in the literature regarding the risk of 
transmission of hepatitis C through tattooing and piercing, the Centers for Disease Control 
and Prevention receives multiple inquiries by health professionals and laypersons for 
information on that matter.
Because of the increase in the practice of tattooing and piercing and the interest of health 
professionals and the public, we conducted a review of the literature to present the best 
available data on the risk of HCV transmission through these 2 modes. The review is 
intended to inform recommendations to prevent and reduce the risk of HCV transmission.
METHODS
Study Identification
Articles addressing the transmission of HCV through tattooing and piercing were identified 
through a literature search using PubMed and Medline. The search was limited to articles 
published from 1994 through July 2011 in all languages. A combination of the Medical 
Subject Headings terms “hepatitis C,” “HCV,” “tattooing,” “tattoo,” and “piercing” was 
used to identify potentially relevant abstracts and articles. Relevant references cited in 
identified studies were also assessed for inclusion. Articles published in languages other 
than English and French were evaluated on the basis of information included in the English 
abstract only. Unpublished, non-peer-reviewed studies were not retrieved because of the 
questionable reliability of such reports. The first author (R. T.) performed the search and 
retrieved the articles. Both authors (R. T. and S. H.) evaluated the validity of inclusion of 
each article and agreed on the strength of evidence in each based on preset ratings (Table 1).
The literature search resulted in the retrieval of 293 published articles or abstracts on HCV 
infection that included information about tattooing and/or piercing exposure. However, 231 
studies were excluded because they were review papers (n = 47), did not measure the risk of 
HCV infection through tattooing or piercing (ie, relied on descriptive statistics and did not 
include measures of association, such as odds ratios (ORs) and relative risk; n = 163), did 
not control for any HCV infection risk factor (eg, drug use, transfusion before 1992, 
hemodialysis, contact with blood from HCV-infected person, and number of sex partners) 
when assessing the risk (n = 14), were duplicate studies (n = 4), were editorials or author 
responses (n = 2), or relied on self-reported HCV infection (n = 1). Therefore, a total of 62 
articles were eligible for inclusion.
Study Rating
We used the Meta-analysis of Observational Studies in Epidemiology and the Grades of 
Recommendation, Assessment, Development, and Evaluation guidelines to evaluate the 
quality of evidence [8, 9]. Table 1 summarizes the criteria used to evaluate and rate the 
strength of the evidence in each study. Final rating consisted of adding the rates in each 
category. Reports were evaluated on the basis of the study design, representativeness of the 
study population, adjustment for other HCV infection risk factors, and use of adequate 
laboratory testing methods for ascertainment of HCV infection. Cohort and case-control 
studies were given the highest rates, followed by cross-sectional studies. Case reports or 
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case series were rated lowest, because the sample size from these types of studies is 
typically insufficient to quantify risk of HCV transmission. Studies that included incident 
cases of HCV infection; a sample size including at least 100 cases for case-control studies 
and 2000 individuals for cross-sectional studies (calculated considering a power of 80%, an 
α of 0.05, and an estimated OR of 2 and taking into account the variability in HCV infection 
and tattoo prevalence rates in different study populations); controlled for other hepatitis C 
risk factors, including mainly IDU and transfusion of blood or blood products; and 
confirmed HCV infection with recombinant immunoblot assay or nucleic acid testing were 
given additional rating.
Analysis
The magnitudes of the risk of HCV transmission through tattooing and piercing were 
presented as adjusted ORs (AORs) obtained by compiling AORs from studies that 
controlled for the most common routes of HCV transmission, particularly IDU. Because of 
the wide variability in the characteristics of study populations, we separately evaluated the 
risk of HCV infection from tattooing in the general population, blood donors, high-risk 
groups (ie, drug users, homeless persons, sex workers, and patients in sexually transmitted 
disease clinics), prisoners, and veterans. High-risk groups, prisoners, and veterans have been 
shown to have higher prevalence rates of IDU and HCV infection than the general 
population [1, 10–12], which could jeopardize analyses and conclusions if they are 
aggregated with low-risk groups. In addition, when information was available in the study, 
we separately assessed the risk of transmission of HCV infection from tattooing and piercing 
performed in professional parlors (ie, commercial venues that are licensed and regulated by 
health authorities), compared with those performed in nonprofessional settings under 
potentially nonsterile conditions (eg, by friends, at home, or in prison).
RESULTS
Association Between HCV Infection and Tattooing in the General Population
Table 2 summarizes findings from studies in the general population. Of 10 case-control 
studies, 6 reported no increased risk of HCV infection from tattooing when they controlled 
for IDU and other risk behaviors [15, 16, 18, 20–22], and 2 studies reported a 2–3 times 
higher risk for HCV infection when the tattoo was received in nonprofessional settings [14, 
17]. One hospital-based case-control study including 64 patients and 128 control subjects 
did not find a significant association between tattooing and HCV infection in univariate 
analysis and, thus, excluded tattooing from the multivariate model [32]. Of the few reports 
showing an association between tattooing and HCV infection, 1 study compared 598 
patients with acute HCV infection with 7221 control subjects with acute hepatitis A virus 
infection [13]. Patients with acute hepatitis A virus infection were younger and lived in other 
geographic areas, compared with those with acute HCV infection, which might affect the 
validity of the findings. Another study recruited 58 patients and 58 control subjects from a 
gastroenterology clinic, which limited generalizability of its findings [19]. More important, 
29% of the originally enrolled study population admitted IDU when requestioned, and 
control subjects were not tested to confirm that they were not HCV infected. Moreover, 
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tattooing was frequently performed by family members or friends using unhygienic 
techniques [19].
A cross-sectional study including >5000 college students in the United States revealed no 
risk of HCV infection when the tattoo was performed in a professional setting (AOR, 0.8; 
95% confidence interval [CI], 0.4–1.7), whereas the risk was significant for tattoos 
performed in nonprofessional settings (AOR, 3.5; 95% CI, 1.4–8.8) [23]. Other large cross-
sectional studies indicated an association between tattooing and HCV infection but did not 
specify venue of tattooing [25, 26, 29]. A cross-sectional hospital-based survey in Brazil 
showed an increased risk of HCV infection among persons having a tattoo; however, more 
than half of individuals received their tattoos in nonprofessional settings using nonsterile 
instruments [27]. Moreover, 26% of those who had a tattoo reported IDU, compared with 
0% of those who did not have a tattoo [33].
Only one early (1991–1992) cross-sectional study conducted among a selected US 
population (minority, indigent, and orthopedic patients) indicated a potential risk of HCV 
transmission by tattooing in commercial parlors [24]. One case report suggested potential 
hepatitis C transmission by tattooing in commercial parlors from reuse of nondisposable 
tattooing needles that are not appropriately sterilized [34].
Association Between HCV Infection and Tattooing Among Blood Donors
Persons with certain high-risk behaviors are excluded from blood donation, and several 
countries require persons who have recently had a tattoo or body piercing to defer from 
blood donation for at least 6 months, leading to lower rates of risk behaviors in this 
population. All studies conducted among blood donors did not inquire about the venue of 
tattooing. As shown in Table 3, almost all studies of these low-risk individuals that 
controlled for major HCV infection risk factors have not reported an increased risk for HCV 
infection from tattooing [37–39, 42–44, 47]. Case-control studies conducted in large 
samples of blood donors in the United States did not show an increased risk of HCV 
transmission from tattooing, but did report significant associations between tattooing and 
IDU [43, 44].
Some studies suggest that tattoos received before 1995 increased the risk of HCV infection, 
whereas those received after 2005 did not [35, 36, 40, 41, 45, 46]. However, none of the 
studies recruited patients with incident cases, limiting the ability to draw temporal causality. 
One study involving blood donors in Canada found that the odds of HCV infection from 
tattooing were much lower among blood donors in 2005 (AOR, 2.9; 95% CI, 1.2–7.0) than 
among blood donors in 1993 (AOR, 8.3; 95% CI, 2.8–24.5) [32]. However, the venue of 
tattooing was not specified.
Association Between HCV Infection and Tattooing Among High-Risk Groups
Table 4 summarizes the findings of studies that assessed the risk of HCV infection from 
tattooing in high-risk groups. Two cohort studies conducted among prisoners in Australia 
reported discrepant findings. The study that recruited a larger sample (n = 488) showed a 
significant association between tattooing and HCV infection [48]; the other study, which did 
not find such an association, recruited 181 prisoners, a smaller number, which might have 
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limited the power to demonstrate statistical significance [49]. Although cohort studies 
followed up with prisoners over >4 years, the presence of tattooing was assessed during their 
lifetime and not necessarily during their time in prison; this hinders temporal linkage 
between tattooing and HCV infection [48, 49].
Results from cross-sectional studies involving incarcerated individuals have been 
inconsistent. Two studies conducted in the United States among incarcerated youths 
reported no increased risk of HCV infection among those who were tattooed, even if the 
tattoo was applied in a nonprofessional setting [56, 58]. However, several studies from other 
countries found a 2–3 times higher likelihood of HCV infection among prisoners who had a 
tattoo [51–55, 57]. Of note, approximately 90% of prisoners received tattoos in 
nonprofessional settings [57]. Case reports of acute HCV infection from tattooing in prison 
suggest that tattooing could be the source of infection [67–69]. One case report documented 
seroconversion in a prisoner after a negative hepatitis C test result, and tattooing in prison 
was the only risk factor during the incubation period [67].
Findings from cross-sectional studies involving injection drug users varied by country, 
duration of injection, and incarceration [59–61]. Although the risk of HCV infection 
increased by 3 times among injection drug users who had tattoos applied in prison or jail, the 
risk was not statistically significant if the tattoos were received outside prison or jail [61]. 
Current noninjecting heroin users who reported never injecting drugs did not have a 
significantly increased risk of HCV infection from tattooing, whereas former injectors who 
had a tattoo had 3 times higher risk of HCV infection [63]. Other studies involving 
noninjection drug users reported a 2–3 times higher risk of HCV infection among those who 
had a tattoo [62, 64], and 1 study specified that the tattoos were applied by friends or 
relatives [64].
Studies involving street youths and homeless persons did not find an association between 
HCV infection and tattoos [65, 70], with 57% of homeless persons reporting IDU and 41% 
of them having shared needles with others [70].
Tattoos are highly prevalent among soldiers. Almost 36% of soldiers in the US Army had at 
least 1 tattoo, and 76% experienced bleeding after the procedure, which might promote 
transmission of blood-borne infections [71]. Studies that recruited >1000 veterans found 
almost 3 times higher risk of HCV infection among veterans with a tattoo, compared with 
those who did not have a tattoo (Table 4) [11, 12, 66]. However, in all studies, the 
researchers did not inquire about the venue of tattooing.
Association Between HCV Infection and Piercing
Table 5 summarizes findings of studies that assessed the risk of HCV infection among those 
who reported having a body or ear piercing. The majority of studies did not distinguish 
between piercings received in professional settings from those received in nonprofessional 
settings. Only 5 of 23 studies reported an increased risk of HCV infection among persons 
with a piercing (AOR, 2.0–7.3) [13, 22, 43, 44, 73]. Of the 5, 2 were conducted among 
blood donors in the United States during the early 1990s [43, 44], with 1 study showing a 
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significant association between ear piercing and HCV infection only among men and no 
association among women [44].
Moreover, a number of cohort, case-control, and cross-sectional studies involving high-risk 
groups did not find significant associations between body piercing and HCV infection in 
univariate analysis and, thus, did not include this variable in the multivariable model [32, 48, 
62, 64]. A cross-sectional study including >5000 college students in the United States did 
not reveal an increased risk of HCV infection among those with a body piercing [23]. Acute 
HCV infection occurred after ear piercing with a gun at a jeweler in an older French woman 
with no other identified risk factor [74]. Swapping body piercing jewelry was also reported 
as a potential source of HCV infection in another case report [75].
DISCUSSION
This article critically reviewed the literature for the risk of transmission of HCV infection 
through tattooing and piercing by distinguishing among different study populations and 
careful examination of potential study limitations. To date, there is no definitive evidence 
that such infections occur when sterile equipment is used. Of note, no outbreaks of HCV 
infection have been detected in the United States that originate from professional tattoo or 
piercing parlors. In addition, recent cohort and case-control studies including samples from 
the general population or blood donors in developed countries did not show an increased 
risk of HCV infection with body or ear piercing.
Although commercial parlors have not been implicated in HCV transmission, such 
transmission could occur at different stages of tattooing and piercing, from the reuse of 
nondisposable needles, inappropriate sterilization of equipment, or reuse of ink 
contaminated with blood from an infected person. Although data on survival of hepatitis C 
in tattooing or piercing equipment are not available, survival of HCV ranges from a few 
days on inanimate surfaces to almost 1 month in propofol solutions [76–79]. Because of the 
potential risk of transmission of blood-borne pathogens through tattooing and piercing, the 
US Occupational Safety and Health Administration includes these practices in their blood-
borne safety standards [80]. In addition, several countries and more than two-thirds of state 
health jurisdictions in the United States have additional regulations for tattoo and piercing 
parlors [81].
Although the majority of reviewed studies failed to report the venue of tattoo and/or 
piercing, studies that specified the location in the general population showed a significant 
increase in risk of HCV infection when the tattoo was done in nonprofessional settings [14, 
17, 19, 23, 27]. In addition, the risk of HCV infection is significant among high-risk groups 
when nonsterile tattooing equipment is used, especially in unregulated settings, such as 
homes or prison (AOR, 2.0–3.6) [48, 57, 61, 64]. Although location of tattooing was not 
specified in all studies including prisoners, this population seems to be at increased risk of 
HCV infection from tattooing, according to the available data [48, 51–56]. Tattooing in 
prison is of particular concern because of the high prevalence of tattooing among 
incarcerated persons, reaching up to 40% in some studies [57, 82]. Tattooing in this setting 
typically is performed using nonsterile equipment, such as guitar strings, paper clips, or 
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sewing needles, which are usually cleaned by heating or use of boiling water [82]. The 
strong association between tattoos received in prison and HCV infection may in part be 
confounded by other high-risk behaviors, such as IDU, or may be a consequence of an 
association between history of imprisonment and dangerous lifestyles. Prisoners with a 
history of IDU were 5 times more likely to have a tattoo and were significantly more likely 
to have acquired the tattoo in prison [57]. Qualitative studies might be helpful to identify 
successful techniques to prevent blood-borne viruses in prison environments and among 
high-risk groups [61].
A major limitation, common to all studies, was the reliance on self-reports for the 
ascertainment of IDU. Tattoos and drugs often coexist, and the risk of HCV infection among 
tattooed individuals consistently has been shown to be related to drug use [57, 59, 63, 65]. 
Of note, in one study, 67% of the participants who initially denied drug use at study entry 
subsequently admitted IDU or intranasal cocaine use [18]. In addition, almost all cohort and 
case-control studies did not recruit patients with incident cases of HCV infection and asked 
about ever having a tattoo or piercing, which hinders drawing temporal causal relationships 
between HCV infection and tattooing or piercing. Finally, most studies did not inquire about 
the venue of receipt of the tattoo or piercing. Therefore, future studies that inquire about 
tattooing and piercing need to specify the venue where they were received to draw more 
scientifically sound conclusions about the association between HCV infection and those 
exposures.
Although our original objective was to conduct a meta-analysis, several of the studies that 
found no association between HCV infection and tattooing or piercing in the univariate 
analysis either did not include those exposures in the multivariable analysis or did not report 
the AOR. Therefore, pooling the results of studies with available ORs would be 
inappropriate and would lead to inaccurate and false conclusions. It is recommended that 
upcoming studies report AORs even if they are not significant to facilitate the conduct of 
meta-analyses in the future.
Despite these limitations, we could evaluate the quality of the evidence in each study. The 
findings emphasize the need to prevent hepatitis C transmission from use of unsterile 
tattooing and piercing equipment, especially in prisons. Because of the increasing 
prevalence of tattooing and piercings, particularly among youths, awareness campaigns 
should highlight the danger of such procedures in unregulated and potentially unsterile 
environments, such as homes and prisons. In addition, tattoo and piercing parlors need to be 
educated about and monitored for use of proper infection control procedures to avoid 
isolated cases of HCV infection and other infections.
References
1. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the 
United States, 1999 through 2002. Ann Intern Med. 2006; 144:705–714. [PubMed: 16702586] 
2. Centers for Disease Control and Prevention. [Accessed 6 September 2011] Viral hepatitis 
surveillance—United States. 2009. Available at: http://www.cdc.gov/hepatitis/Statistics/
2009Surveillance/PDFs/2009HepSurveillanceRpt.pdf.
Tohme and Holmberg Page 7













3. Williams IT, Bell BP, Kuhnert W, Alter MJ. Incidence and transmission patterns of acute hepatitis 
C in the United States, 1982–2006. Arch Intern Med. 2011; 171:242–248. [PubMed: 21325115] 
4. Laumann AE, Derick AJ. Tattoos and body piercings in the United States: a national data set. J Am 
Acad Dermatol. 2006; 55:413–421. [PubMed: 16908345] 
5. Mayers LB, Chiffriller SH. Body art (body piercing and tattooing) among undergraduate university 
students: “then and now.”. J Adolesc Health. 2008; 42:201–203. [PubMed: 18207100] 
6. Carroll ST, Riffenburgh RH, Roberts TA, Myhre EB. Tattoos and body piercings as indicators of 
adolescent risk-taking behaviors. Pediatrics. 2002; 109:1021–1027. [PubMed: 12042538] 
7. Stieger S, Pietschnig J, Kastner CK, Voracek M, Swami V. Prevalence and acceptance of tattoos 
and piercings: a survey of young adults from the southern German-speaking area of central Europe. 
Percept Mot Skills. 2010; 110:1065–1074. [PubMed: 20865994] 
8. Stroup D, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a 
proposal for reporting. JAMA. 2000; 283:2008–2012. [PubMed: 10789670] 
9. Atkins D, Best D, Briss PA, et al. (GRADE) Working Group. Grading quality of evidence and 
strength of recommendations. BMJ. 2004; 328:1490–1494. [PubMed: 15205295] 
10. Vescio MF, Longo B, Babudieri S, et al. Correlates of hepatitis C virus seropositivity in prison 
inmates: a meta-analysis. J Epidemiol Community Health. 2008; 62:305–313. [PubMed: 
18339822] 
11. Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL. VA Cooperative 
Study Group 488. Elevated prevalence of hepatitis C infection in users of United States veterans 
medical centers. Hepatology. 2005; 41:88–96. [PubMed: 15619249] 
12. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection at an 
urban veterans administration medical center. Hepatology. 2001; 34:1200–1205. [PubMed: 
11732010] 
13. Mariano A, Mele A, Tosti ME, et al. Role of beauty treatment in the spread of parenterally 
transmitted hepatitis viruses in Italy. J Med Virol. 2004; 74:216–220. [PubMed: 15332269] 
14. Hand WL, Vasquez Y. Risk factors for hepatitis C on the Texas-Mexico border. Am J 
Gastroenterol. 2005; 100:2180–2185. [PubMed: 16181366] 
15. Delarocque-Astagneau E, Pillonel J, De Valk H, Perra A, Laperche S, Desenclos JC. An incident 
case-control study of modes of hepatitis C virus transmission in France. Ann Epidemiol. 2007; 
17:755–762. [PubMed: 17728145] 
16. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G. for the GERMIVIC Study Group. 
A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of 
infection. J Viral Hepat. 2006; 13:775–782. [PubMed: 17052278] 
17. Lasher LE, Elm JL, Hoang Q, et al. A case control investigation of hepatitis C risk factors in 
Hawaii. Hawaii Med J. 2005; 64:296–304. [PubMed: 16379222] 
18. Silverman AL, Sekhon JS, Saginaw SJ, Wiedbrauk D, Balasubramaniam M, Gordon SC. Tattoo 
application is not associated with an increased risk for chronic viral hepatitis. Am J Gastroenterol. 
2000; 95:1312–1315. [PubMed: 10811345] 
19. Balasekaran R, Bulterys M, Jamal MM, et al. A case-control study of risk factors for sporadic 
hepatitis C virus infection in the southwestern United States. Am J Gastroenterol. 1999; 94:1341–
1346. [PubMed: 10235216] 
20. Dubois F, Desenclos JC, Mariotte N, Goudeau A. The Collaborative Study Group. Hepatitis C in a 
French population-based survey, 1994: seroprevalence, frequency of viremia, genotype 
distribution, and risk factors. Hepatology. 1997; 25:1490–1496. [PubMed: 9185773] 
21. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk 
factors based on a nationwide survey. J Med Virol. 1999; 59:290–296. [PubMed: 10502258] 
22. Mele A, Corona R, Tosti ME, et al. Beauty treatments and risk of parenterally transmitted 
hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis. 1995; 27:441–
444. [PubMed: 8588131] 
23. Hwang LY, Kramer JR, Troisi C, et al. Relationship of cosmetic procedures and drug use to 
hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology. 2006; 44:341–
351. [PubMed: 16871571] 
Tohme and Holmberg Page 8













24. Haley RW, Fisher RP. Commercial tattooing as a potentially important source of hepatitis C 
infection: clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic 
status. Medicine. 2001; 80:134–151. [PubMed: 11307589] 
25. King LA, Le Strat Y, Meffre C, Delarocque-Astagneau E, Desenclos JC. Assessment and proposal 
of a new combination of screening criteria for hepatitis C in France. Eur J Public Health. 2009; 
19:527–533. [PubMed: 19667051] 
26. Perez CM, Suarez E, Torres EA, Roman K, Colon V. Seroprevalence of hepatitis C virus and 
associated risk behaviors: a population-based study in San Juan, Puerto Rico. Int J Epidemiol. 
2005; 34:593–599. [PubMed: 15802378] 
27. Nishioka, S de A.; Gyorkos, TW.; Joseph, L.; Collet, JP.; Maclean, JD. Tattooing and risk for 
transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the 
conditions in which they were performed. Epidemiol Infect. 2002; 128:63–71. [PubMed: 
11895092] 
28. La Torre G, Miele L, Mannocci A, et al. Correlates of HCV seropositivity among familial contacts 
of HCV infected patients. BMC Public Health. 2006; 6:237. [PubMed: 16999861] 
29. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological 
survey of HCV infection in Catalonia, Spain. J Med Virol. 2001; 65:688–693. [PubMed: 
11745932] 
30. Brusaferro S, Barbone F, Andrian P, et al. A study on the role of the family and other risk factors 
in HCV transmission. Eur J Epidemiol. 1999; 15:125–132. [PubMed: 10204641] 
31. Campello C, Poli A, Dal Molin G, Bezossi-Valentini F. Seroprevalence, viremia and genotype 
distribution of hepatitis C virus: a community-based population study in northern Italy. Infection. 
2002; 30:7–12. [PubMed: 11876521] 
32. Kim YS, Ahn YO, Kim DW. A case-control study on the risk factors of hepatitis C virus infection 
among Koreans. J Korean Med Sci. 1996; 11:38–43. [PubMed: 8703369] 
33. Nishioka, S de A.; Gyorkos, TW.; Joseph, L.; Collet, JP.; Maclean, JD. Tatooing and transfusion-
transmitted diseases in Brazil: a hospital-based cross-sectional matched study. Eur J Epidemiol. 
2003; 18:441–449. [PubMed: 12889691] 
34. Sun DX, Zhang FG, Geng YQ, Xi DS. Hepatitis C transmission by cosmetic tattooing in women. 
Lancet. 1996; 347:541. [PubMed: 8596286] 
35. Goldman M, Xi G, Yi QL, Fan W, O’Brien SF. Reassessment of deferrals for tattooing and 
piercing. Transfusion. 2009; 49:648–654. [PubMed: 19171003] 
36. O’Brien SF, Fan W, Xi G, et al. Declining hepatitis C rates in first time blood donors: insight from 
surveillance and case-control risk factor studies. Transfusion. 2008; 48:902–909. [PubMed: 
18208409] 
37. Kerzman H, Green MS, Shinar E. Risk factors for hepatitis C virus infection among blood donors 
in Israel: a case-control study between native Israelis and immigrants from the former Soviet 
Union. Transfusion. 2007; 47:1189–1196. [PubMed: 17581153] 
38. Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE. Risk factors for 
hepatitis C virus infection among blood donors in northern Thailand. Transfusion. 2004; 44:1433–
1440. [PubMed: 15383015] 
39. Tanwandee T, Piratvisuth T, Phornphutkul K, Mairiang P, Permpikul P, Poovorawan Y. Risk 
factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study. 
J Med Assoc Thai. 2006; 89(Suppl 5):S79–S83. [PubMed: 17722300] 
40. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of 
hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology. 1999; 
116:893–899. [PubMed: 10092311] 
41. Brandao AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in 
southern Brazil: a case-control study. BMC Gastroenterol. 2002; 2:18. [PubMed: 12169200] 
42. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a 
case-control study. J Gastroenterol Hepatol. 2002; 17:1092–1097. [PubMed: 12201870] 
43. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United 
States blood donors. Hepatology. 2000; 31:756–762. [PubMed: 10706569] 
Tohme and Holmberg Page 9













44. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in 
blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334:1691–1696. 
[PubMed: 8637513] 
45. Neal KR, Jones DA, Killey D, James V. Risk factors for hepatitis C virus infection. A case- control 
study of blood donors in the Trent region (UK). Epidemiol Infect. 1994; 112:595–601. [PubMed: 
8005225] 
46. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among 
hepatitis C virus RNA positive Swedish blood donors—the role of parenteral and sexual 
transmission. Scand J Infect Dis. 1995; 27:99–104. [PubMed: 7544914] 
47. Khin M, Oo SS, Oo KM, Shimono K, Koide N, Okada S. Prevalence and factors associated with 
hepatitis C virus infection among Myanmar blood donors. Acta Med Okayama. 2010; 64:317–321. 
[PubMed: 20975765] 
48. Teutsch S, Luciani F, Scheuer N, et al. Incidence of primary hepatitis C infection and risk factors 
for transmission in an Australian prisoner cohort. BMC Public Health. 2010; 10:633. [PubMed: 
20964864] 
49. Butler T, Kariminia A, Levy M, Kaldor J. Prisoners are at risk for hepatitis C transmission. Eur J 
Epidemiol. 2004; 19:1119–1122. [PubMed: 15678792] 
50. Russell M, Chen MJ, Nochajski TH, Testa M, Zimmerman SJ, Hughes PS. Risky sexual behavior, 
bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a 
sexually transmitted disease clinic. Am J Public Health. 2009; 99:S173–S179. [PubMed: 
19218181] 
51. Kheirandish P, SeyedAlninaghi SA, Jahani MR, et al. Prevalence and correlates of hepatitis C 
infection among male injection drug users in detention, Tehran, Iran. J Urban Health. 2009; 
86:902–908. [PubMed: 19844670] 
52. Coelho HC, de Olivera SA, Miguel JC, et al. Predictive markers for hepatitis C virus infection 
among Brazilian inmates. Rev Soc Bras Med Trop. 2009; 42:369–372. [PubMed: 19802469] 
53. Lai SW, Chang WL, Peng CY, Liao KF. Viral hepatitis among male amphetamine-inhaling 
abusers. Intern Med J. 2007; 37:472–477. [PubMed: 17445007] 
54. Liao KF, Lai SW, Chang WL, Hsu NY. Screening for viral hepatitis among male non-drug-abuse 
prisoners. Scand J Gastroenterol. 2006; 41:969–973. [PubMed: 16803696] 
55. Babudieri S, Longo B, Sarmati L, et al. Correlates of HIV, HBV, and HCV infections in a prison 
inmate population: results from a multicentre study in Italy. J Med Virol. 2005; 76:311–317. 
[PubMed: 15902712] 
56. Bair RM, Baillargeon JG, Kelly PJ, et al. Prevalence and risk factors for hepatitis C virus infection 
among adolescents in detention. Arch Pediatr Adolesc Med. 2005; 159:1015–1018. [PubMed: 
16275789] 
57. Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons—not such a pretty picture. Am J Infect 
Control. 2007; 35:477–480. [PubMed: 17765561] 
58. Murray KF, Richardson LP, Morishima C, Owens JWM, Gretch DR. Prevalence of hepatitis C 
virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 
2003; 111:153–157. [PubMed: 12509569] 
59. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, 
HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect. 2009; 
58:375–382. [PubMed: 19328555] 
60. Mehta SH, Vogt SL, Srikrishnan AK, et al. Epidemiology of hepatitis C virus infection and liver 
disease among injection drug users (IDUs) in Chennai, India. Ind J Med Res. 2010; 132:706–714.
61. Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing 
and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting 
drug users in New Mexico, USA. Epidemiol Infect. 2001; 127:475–484. [PubMed: 11811881] 
62. Nurutdinova D, Abdallah AB, Bradford S, O’Leary CC, Cottler LB. Risk factors associated with 
hepatitis C among female substance users enrolled in community-based HIV prevention studies. 
BMC Res Notes. 2011; 4:126. [PubMed: 21492467] 
Tohme and Holmberg Page 10













63. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent 
HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir 
Immune Defic Syndr. 2002; 30:448–456. [PubMed: 12138352] 
64. Howe CJ, Fuller CM, Ompad DC, et al. Association of sex, hygiene and drug equipment sharing 
with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol 
Depend. 2005; 79:389–395. [PubMed: 16102381] 
65. Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus 
infection among street youths. CMAJ. 2001; 165:557–560. [PubMed: 11563207] 
66. Zuniga IA, Chen JJ, Lane DS, Allmer J, Jimenez-Lucho VE. Analysis of hepatitis C screening 
program for US veterans. Epidemiol Infect. 2006; 134:249–257. [PubMed: 16490127] 
67. Tsang TH, Horowitz E, Vugia DC. Transmission of hepatitis C through tattooing in a United States 
prison. Am J Gastroenterol. 2001; 96:1304–1305. [PubMed: 11316197] 
68. Post JJ, Dolan KA, Whybin LR, Carter IW, Haber PS, Lloyd AR. Acute hepatitis C virus infection 
in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust. 2001; 
174:183–184. [PubMed: 11270759] 
69. Thompson SC, Hernberger F, Wale E, Crofts N. Hepatitis C transmission through tattooing: a case 
report. Aust N Z J Public Health. 1996; 20:317–318. [PubMed: 8768424] 
70. Sherriff LC, Mayon-White RT. A survey of hepatitis C prevalence amongst the homeless 
community of Oxford. J Public Health Med. 2003; 25:358–361. [PubMed: 14747596] 
71. Armstrong ML, Murphy KP, Sallee A, Watson MG. Tattooed army soldiers: examining the 
incidence, behavior, and risk. Mil Med. 2000; 165:135–141. [PubMed: 10709376] 
72. Bruneau J, Daniel M, Kestens Y, Abrahamowicz M, Zang G. Availability of body art facilities and 
body art piercing do not predict hepatitis C acquisition among injection drug users in Montreal, 
Canada: results from a cohort study. Int J Drug Policy. 2010; 21:477–484. [PubMed: 20541926] 
73. He Y, Zhang J, Zhong L, et al. Prevalence of and risk factors for hepatitis C virus infection among 
blood donors in Chengdu, China. J Med Virol. 2011; 83:616–621. [PubMed: 21328375] 
74. Grasset D, Borderes C, Escudie L, et al. Le piercing des oreilles responsable d’une contamination 
par le virus de l’hépatite C [Hepatitis C virus from ear piercing]. Gastroenterol Clin Biol. 2004; 
28:501–508. [PubMed: 15243331] 
75. Daniel AR, Sheha T. Transmission of hepatitis C through swapping body jewelry. Pediatrics. 2005; 
116:1264–1265. [PubMed: 16264024] 
76. Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: 
implication for transmission among injection drug users. J Infect Dis. 2010; 202:984–990. 
[PubMed: 20726768] 
77. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in 
plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol. 2007; 
28:519–524. [PubMed: 17464909] 
78. Doerrbecker J, Friesland M, Ciesek S, et al. Inactivation and survival of hepatitis C virus on 
inanimate surfaces. J Infect Dis. 2011; 204:1830–1838. [PubMed: 22013220] 
79. Steinman E, Ciesek S, Friesland M, Erichsen TJ, Pietschmann T. Prolonged survival of hepatitis C 
virus in the anesthetic propofol. Clin Infect Dis. 2011; 53:963–964. [PubMed: 21880582] 
80. Occupational Safety and Health Administration (OSHA). [Accessed 28 November 2011] 
Occupational safety and health standard: bloodborne pathogens. Available at: http://
www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.
81. Armstrong ML. Tattooing, body piercing, and permanent cosmetics: a historical and current view 
of state regulations, with continuing concerns. J Environ Health. 2005; 67:38–43. [PubMed: 
15856663] 
82. Strang J, Heuston J, Whiteley C, et al. Is prison tattooing a risk behaviour for HIV and other 
viruses? Results from a national survey of prisoners in England and Wales. Criminal Behav Ment 
Health. 2000; 10:60–66.
Tohme and Holmberg Page 11

























Tohme and Holmberg Page 12
Table 1
Rating Criteria Used to Assess the Strength of the Evidence for Hepatitis C Virus Transmission Through 
Tattooing and Piercing
Characteristic Description of Study (Ratinga)
Study design Case series/report (1), cross-sectional (2), case-control (3), cohort (4)
Study populationb Hospital or clinic based (1), general population/surveillance (2)
Comparison population Not representative (1), representative (2)
Outcome data Prevalence (1), incidence (2)
Sample size <100 cases for case-control or <2000 for cross-sectional studies (1),
≥100 cases for case-control or ≥2000 for cross-sectional studies (2)
Included and adjusted for confounders Excluded IDU and transfusion (1), adjusted for IDU and transfusion (2)
Assessment of HCV infection Serology only (1), serology and confirmatory RIBA or HCV RNA (2)
Specified venue of tattoo/piercing No (1), yes (2)
Abbreviations: HCV, hepatitis C virus; IDU, injection drug use; RIBA, recombinant immunoblot assay.
a
Higher number indicates increased strength of evidence.
b
For studies not including blood donors or high-risk groups.
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